Qube Research & Technologies (QRT)
FBLG icon

Qube Research & Technologies (QRT)’s FibroBiologics FBLG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-842
Closed -$3.79K – 4234
2025
Q4 		$3.79K Sell
842
-656
-44% -$4.62K ﹤0.01% 3547
2025
Q3 		$16.4K Sell
1,498
-207
-12% -$2.48K ﹤0.01% 3305
2025
Q2 		$21.2K Buy
+1,705
New +$30.8K ﹤0.01% 3252

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Qube Research & Technologies (QRT)'s FBLG Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 842 shares — an estimated $3.79K sold.

Qube Research & Technologies (QRT) first reported a position in FBLG in Q2 2025 and held it in 3 quarters. The position peaked at $21.2K in Q2 2025. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 842 FibroBiologics shares in Q1 2026, an estimated $3.79K.
  • Qube Research & Technologies (QRT) first reported a position in FibroBiologics in Q2 2025 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s FibroBiologics position peaked at $21.2K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.